Skip to main content
. Author manuscript; available in PMC: 2019 May 16.
Published in final edited form as: ACS Chem Neurosci. 2018 Feb 13;9(5):1141–1151. doi: 10.1021/acschemneuro.7b00495

Figure 4.

Figure 4

Illustration of the in vitro partial agonist pharmacology of 8 at the mMC1R. These data were normalized to an NDP-MSH response as has been previously reported.59–61